Home Tags Pharmaceutical
A Walgreens spokesperson told Business Insider that six million customers visit its locations every single day.
Merck climbs after announcing massive growth for its top cancer drug, which is now on pace to generate $10 billion a year
Keytruda sales rose 58%, making $2.63 billion in the second quarter. The drug's success pushes Merck ahead of its rival Bristol-Myers Squibb.
CVS and other drug-plan providers surge after the Trump administration scraps a key part of its push to lower prices
The plan would have banned pharmacy benefit managers from profiting on deals cut between drugmakers and insurance plans.
A new study finds certain antidepressants and antipsychotic drugs may increase your risk of dementia, and you may not even know you’re on them
Anticholinergic drugs work by blocking a specific brain chemical involved in muscle contractions. Their risks may be greater in middle age and beyond.
AbbVie expects the acquisition to generate at least $2 billion in pre-tax synergies and cost reductions within three years.
Wall Street thinks CBD could be a $16 billion industry by 2025. Here’s what the cannabis compound does to your brain and body.
Cannabidiol, or CBD, is a compound in marijuana that's not linked with a high. Here's what we know about its mental and physical effects.
Elizabeth Warren is picking a fight with the billionaire family that is accused of deceptively marketing opioids like OxyContin
Warren targeted the Sacklers while laying out her $100 billion plan to fight the opioid crisis, which she would fund with her "ultra-millionaire" tax.
Elizabeth Warren proposes paying for an ambitious plan to spend $100 billion fighting the opioid crisis with her new tax on the ultra-rich
The money would support a whole range of services — including early intervention, addiction treatment, mental-health care, and housing support.
Drugs that cost as much as a house are on the way to treat rare and devastating diseases. The US is scrambling to figure out how to pay for them.
The cost of gene therapies will put a huge financial strain on the US health system as new products become available to treat more common diseases.
A depression drug that’s been called ‘the most important discovery in half a century’ just got a big step closer to FDA approval
Esketamine, a first-of-its-kind depression drug made by Johnson & Johnson, got a big nod on Tuesday from a group of experts convened by regulators.